Interaction Guide · Research summary

Can I take L-5-HTP with Tranylcypromine?

Review L-5-HTP with Tranylcypromine: possible adverse effects, preparation details, evidence limits, and sources.

Prepared by Dr. Edward M.Kim, PharmD · Clinical Director, SupplementSafety editorial team

Research summary published · Prepared · Editorial update

The short answer

Do not take 5-HTP with tranylcypromine. Parnate prescribing information explicitly lists hydroxytryptophan as contraindicated because of serotonin-syndrome risk. Research comparing the two as separate treatments does not demonstrate that taking them together is safe.

What this answer covers

Oral L-5-hydroxytryptophan with oral tranylcypromine tablets. This does not identify a safe amount, equate 5-HTP with L-tryptophan, or clear a mixed botanical product.

Supplement or preparation
L-5-HTP
Medication ingredient
tranylcypromine

The warning names 5-HTP

Hydroxytryptophan appears in the tranylcypromine label's interaction table. This is more specific than the checker's original generic wording about "side-effect or safety risks."

Why a study mentioning both can mislead

An older study compared 5-HTP with tranylcypromine in treatment periods. The presence of both names in its title does not mean the participants took both at once or that a safe combination was tested.

Do not try an hours-apart schedule

There is no supported spacing method here. If you want to change treatment, ask the prescriber about discontinuation and the required interval before another serotonergic product. Do not make that change yourself.

Recognize possible serotonin toxicity

Confusion or agitation with fever, heavy sweating, tremor, muscle stiffness or jerking needs urgent assessment. Tell the clinician about tranylcypromine and the exact 5-HTP or mood-supplement product.

Evidence and practical considerations

Side effects & toxicity

PARNATE Table 4 explicitly contraindicates hydroxytryptophan and identifies serotonin syndrome as the predominant concern. The located comparative clinical study tested alternatives, not simultaneous treatment.

Exact scope
Oral L-5-hydroxytryptophan with oral tranylcypromine tablets. This does not identify a safe amount, equate 5-HTP with L-tryptophan, or clear a mixed botanical product. with Oral tranylcypromine tablets; current sulfate-tablet labeling uses the named active ingredient.
Medication form and route
oral

What remains uncertain

  • No reliable exact-pair event rate was established. A comparison study is not contrary coadministration evidence.

Factors that may matter: Exact supplement preparation and complete concomitant-medication list require assessment..

Research conclusion: supported with conditions · Evidence assessment: moderate

Read the supporting source summaries

Source 1: Current U.S. prescribing information

dailymed.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients prescribed oral tranylcypromine sulfate tablets.

The label contraindicates sympathomimetic supplements, hydroxytryptophan, tryptophan and SAM-e; it names St. John's wort in the serotonin-syndrome warning and lists excessive caffeine among exposures to avoid.

How this applies: Primary authority for exact tranylcypromine tablet precautions. Named supplements and class-based applications are kept distinct.

A labeled contraindication is not a measurement of the frequency of an event with each product; L-tyrosine and Panax ginseng are not individually named.

Source 2: Open controlled comparative human study

pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026

Population: Patients with major depression not responding to previous reuptake inhibitors.

Tranylcypromine responses exceeded responses to 5-HTP. The study compared treatments; it does not establish their concurrent safety.

How this applies: Abstract only; must not misclassify an alternative-treatment comparison as a coadministration study.

Abstract only; must not misclassify an alternative-treatment comparison as a coadministration study.

Research assessment: · Open full citations ↗

Review and change history

Publication status
Published research summary
Clinical review
Not yet recorded
DateUpdate
Article prepared
Initial targeted research draft. Inspected source material, adjudicated the current checker statements, and recorded preparation limits. Clinical review has not occurred.
Research summary published

Article revision: e4a7352ae95b3bce

This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.

Full citations require verification. Reading this answer and the source summaries does not.

Taking other supplements or medications?

Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.

Open the interaction checker

Information, not medical advice. Do not change prescribed treatment based on this guide.